MGX Sale Disclosure
Wapnick Pamela · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$2.21K
Wapnick Pamela Chief Financial Officer
MGX
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
MGX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,911 shares @ $1.16
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-387786
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2.21K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. MGX Current | Sale | Sep 8, 2026 | $2.21K |